(Q40505841)

21 September 2017

title

Reconstitution and analysis of soluble inhibin and activin receptor complexes in a cell-free system (English)

1 reference

21 September 2017

Elisabetta del Re

1

1 reference

21 September 2017

Yisrael Sidis

2

1 reference

21 September 2017

David A Fabrizio

3

1 reference

21 September 2017

Herbert Y Lin

4

1 reference

21 September 2017

Alan Schneyer

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

8 October 2004

1 reference

Journal of Biological Chemistry

21 September 2017

published in

1 reference

21 September 2017

volume

279

1 reference

21 September 2017

issue

51

1 reference

21 September 2017

page(s)

53126-53135

1 reference

Genetic analysis of the mammalian transforming growth factor-beta superfamily

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Activin B: precursor sequences, genomic structure and in vitro activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Functional analysis of activins during mammalian development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Activins are critical modulators of growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Inhibin and activin locally regulate rat ovarian folliculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Expression cloning of an activin receptor, a predicted transmembrane serine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Expression cloning and characterization of the TGF-beta type III receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Differential Binding and Neutralization of Activins A and B by Follistatin and Follistatin Like-3 (FSTL-3/FSRP/FLRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Cripto forms a complex with activin and type II activin receptors and can block activin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Enhancement of the antagonistic potency of transforming growth factor-beta receptor extracellular domains by coiled coil-induced homo- and heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Different phenotypes for mice deficient in either activins or activin receptor type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Inhibin is an antagonist of bone morphogenetic protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M408090200

21 January 2018

Identifiers

DOI

10.1074/JBC.M408090200

1 reference

21 September 2017

1 reference